Skip to main content
SpringerLink
Log in

Renin-Angiotensin-System-Blocker bei Diabetes mellitus

Eine zwingende Indikation?

Renin-angiotensin system blockers in diabetes mellitus

A compelling indcation?

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Yusuf S, Pepine CJ, Garces C et al (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173–1178

    Article  CAS  PubMed  Google Scholar 

  2. Viberti G, Mogensen CE, Groop LC, Pauls JF, European Microalbuminuria Captopril Study Group (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275–279

    Article  CAS  PubMed  Google Scholar 

  3. American Diabetes Association (2015) Standards of medical care in diabetes–2015: summary of revisions. Diabetes Care 38(Suppl 1):S4

    Google Scholar 

  4. Weber MA, Schiffrin EL, White WB et al (2014) Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 32:3–15

    Article  CAS  PubMed  Google Scholar 

  5. Mancia G, Fagard R, Narkiewicz K et al (2013) Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357

    Article  CAS  PubMed  Google Scholar 

  6. James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507–520

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik – Diabetologie, Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Deutschland

    M. Jecht

Authors
  1. M. Jecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Jecht.

Ethics declarations

Interessenkonflikt

M. Jecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jecht, M. Renin-Angiotensin-System-Blocker bei Diabetes mellitus. Diabetologe 12, 203–204 (2016). https://doi.org/10.1007/s11428-016-0087-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-016-0087-4

Search

Navigation